201 related articles for article (PubMed ID: 20144859)
1. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia.
Bergenstrom A; McLeod R; Sharma M; Mesquita F; Dorabjee J; Atun R; Lewis G; Rao JV
Int J Drug Policy; 2010 Mar; 21(2):107-9. PubMed ID: 20144859
[TBL] [Abstract][Full Text] [Related]
2. Moving from a project to programmatic response: scaling up harm reduction in Asia.
Chatterjee A; Sharma M
Int J Drug Policy; 2010 Mar; 21(2):134-6. PubMed ID: 20079618
[TBL] [Abstract][Full Text] [Related]
3. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
4. The Global Fund's leadership on harm reduction: 2002-2009.
Atun R; Kazatchkine M
Int J Drug Policy; 2010 Mar; 21(2):103-6. PubMed ID: 20171865
[TBL] [Abstract][Full Text] [Related]
5. Global Fund investments in harm reduction from 2002 to 2009.
Bridge J; Hunter BM; Atun R; Lazarus JV
Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
[TBL] [Abstract][Full Text] [Related]
6. Improving the data to strengthen the global response to HIV among people who inject drugs.
Mathers B; Cook C; Degenhardt L
Int J Drug Policy; 2010 Mar; 21(2):100-2. PubMed ID: 20144539
[TBL] [Abstract][Full Text] [Related]
7. Young people and drugs: next generation of harm reduction.
Merkinaite S; Grund JP; Frimpong A
Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
[TBL] [Abstract][Full Text] [Related]
8. Injection drug use, HIV and the current response in selected low-income and middle-income countries.
Bergenstrom AM; Abdul-Quader AS
AIDS; 2010 Sep; 24 Suppl 3():S20-9. PubMed ID: 20926924
[TBL] [Abstract][Full Text] [Related]
9. Asia can afford universal access for AIDS prevention and treatment.
Komatsu R; McLeod R; Sarkar S; Siripong N; Gupta I; Tangcharoensathien V; Brown T; Jeugmans J; Avila-Figueroa C; Atun R
AIDS; 2010 Sep; 24 Suppl 3():S72-9. PubMed ID: 20926931
[TBL] [Abstract][Full Text] [Related]
10. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
11. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
Limbu B
Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
[TBL] [Abstract][Full Text] [Related]
12. Islam and harm reduction.
Kamarulzaman A; Saifuddeen SM
Int J Drug Policy; 2010 Mar; 21(2):115-8. PubMed ID: 20006483
[TBL] [Abstract][Full Text] [Related]
13. Learning from HIV epidemics among injecting drug users.
Jarlais DC
Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
15. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
[TBL] [Abstract][Full Text] [Related]
16. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
Donoghoe MC; Verster A; Pervilhac C; Williams P
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
[TBL] [Abstract][Full Text] [Related]
17. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
Bobrova N; Sarang A; Stuikyte R; Lezhentsev K
Int J Drug Policy; 2007 Aug; 18(4):313-8. PubMed ID: 17689380
[TBL] [Abstract][Full Text] [Related]
18. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F; Fatima M
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
[TBL] [Abstract][Full Text] [Related]
19. Harm reduction programmes in the Asia--Pacific Region.
Reid G; Devaney ML; Baldwin S
Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
[TBL] [Abstract][Full Text] [Related]
20. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
